Alexander Hieu Nguyen - 24 Jun 2021 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role
General Counsel and Corporate Secretary
Signature
/s/ Alexander Hieu Nguyen
Issuer symbol
UBX
Transactions as of
24 Jun 2021
Transactions value $
$0
Form type
4
Date filed
28 Jun 2021, 17:28
Next filing
15 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UBX Common Stock, $0.0001 par value Award $0 +5.21K $0.00 5.21K 24 Jun 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UBX Stock Option (Right to Buy) Award $0 +20.8K $0.00 20.8K 24 Jun 2021 Common Stock 20.8K $4.18 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") which vest in equal annual installments over a three year period measured from June 24, 2021. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
F2 Includes RSUs which vest over time measured from the grant date.
F3 Shares subject to the stock option vest and become exercisable in successive, equal monthly installments over a 48-month period commencing on June 24, 2021 (the "Vesting Commencement Date"), so that 100% of the shares become fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Remarks:

General Counsel and Corporate Secretary